Literature DB >> 15793581

Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease.

Jingmei Lin1, Sanjeevkumar R Patel, Xu Cheng, Eun Ah Cho, Inna Levitan, Matthew Ullenbruch, Sem H Phan, John M Park, Gregory R Dressler.   

Abstract

The bone morphogenetic proteins (BMPs) profoundly affect embryonic development, differentiation and disease. BMP signaling is suppressed by cysteine-rich domain proteins, such as chordin, that sequester ligands from the BMP receptor. We describe a novel protein, KCP, with 18 cysteine-rich domains. Unlike chordin, KCP enhances BMP signaling in a paracrine manner. Smad1-dependent transcription and phosphorylated Smad1 (P-Smad1) levels are increased, as KCP binds to BMP7 and enhances binding to the type I receptor. In vivo, Kcp(-/-) mice are viable and fertile. Because BMPs have a pivotal role in renal disease, we examined the phenotype of Kcp(-/-) mice in two different models of renal injury. Kcp(-/-) animals show reduced levels of P-Smad1, are more susceptible to developing renal interstitial fibrosis, are more sensitive to tubular injury and show substantial pathology after recovery. The data indicate an important role for KCP in attenuating the pathology of renal fibrotic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793581     DOI: 10.1038/nm1217

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  61 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

2.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.

Authors:  Bernhard Bielesz; Yasemin Sirin; Han Si; Thiruvur Niranjan; Antje Gruenwald; Seonho Ahn; Hideki Kato; James Pullman; Manfred Gessler; Volker H Haase; Katalin Susztak
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

3.  Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.

Authors:  Katri Koli; Marjukka Myllärniemi; Kirsi Vuorinen; Kaisa Salmenkivi; Merja J Ryynänen; Vuokko L Kinnula; Jorma Keski-Oja
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.

Authors:  Motoko Yanagita; Tomohiko Okuda; Shuichiro Endo; Mari Tanaka; Katsu Takahashi; Fumihiro Sugiyama; Satoshi Kunita; Satoru Takahashi; Atsushi Fukatsu; Masashi Yanagisawa; Toru Kita; Takeshi Sakurai
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

Review 5.  Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Authors:  Imran H A Ali; Derek P Brazil
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 6.  BMP signaling and its modifiers in kidney development.

Authors:  Ryuichi Nishinakamura; Masaji Sakaguchi
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

7.  The Groucho protein Grg4 suppresses Smad7 to activate BMP signaling.

Authors:  Peng Zhang; Gregory R Dressler
Journal:  Biochem Biophys Res Commun       Date:  2013-10-05       Impact factor: 3.575

8.  Tenectin recruits integrin to stabilize bouton architecture and regulate vesicle release at the Drosophila neuromuscular junction.

Authors:  Qi Wang; Tae Hee Han; Peter Nguyen; Michal Jarnik; Mihaela Serpe
Journal:  Elife       Date:  2018-06-14       Impact factor: 8.140

9.  Kielin/chordin-like protein attenuates both acute and chronic renal injury.

Authors:  Abdul Soofi; Peng Zhang; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

10.  Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity.

Authors:  Jin-Li Zhang; Lucy J Patterson; Li-Yan Qiu; Daria Graziussi; Walter Sebald; Matthias Hammerschmidt
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.